Verition Fund Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-54,805
| Closed | -$284K | – | 2843 |
|
|
2024
Q3 | $284K | Buy |
54,805
+10,501
| +24% | +$54.5K | ﹤0.01% | 2004 |
|
|
2024
Q2 | $114K | Buy |
44,304
+22,340
| +102% | +$57.4K | ﹤0.01% | 2065 |
|
|
2024
Q1 | $108K | Buy |
+21,964
| New | +$108K | ﹤0.01% | 1970 |
|
|
2023
Q2 | – | Sell |
-7,373
| Closed | -$237K | – | 2312 |
|
|
2023
Q1 | $237K | Buy |
+7,373
| New | +$237K | ﹤0.01% | 1527 |
|
|
2018
Q2 | – | Sell |
-7,567
| Closed | -$233K | – | 1299 |
|
|
2018
Q1 | $233K | Buy |
+7,567
| New | +$233K | 0.02% | 887 |
|